S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Dynex Capital, Inc. Announces $50.0 Million Share Repurchase Program (2014/12/17)|
|Dynex Capital, Inc. Declares Fourth Quarter 2014 Common Dividend of $0.25, Series A Preferred Dividend of $0.53125, and Series B Preferred Dividend of $0.4765625 (2014/12/15)|
|Dynex Capital, Inc. Reports Third Quarter 2014 Results (2014/11/4)|
|Dynex Capital, Inc. to Present at the Southwest IDEAS Investor Conference (2014/11/17)|
|Oncotype DX® DCIS Score™ Represents Breakthrough in Personalizing Treatment of Pre-Invasive Breast Cancer (2014/12/12)|
|Genomic Health Announces Presentation of First Prospective Outcomes Study of Oncotype DX® Breast Cancer Test|
|2014 San Antonio Breast Cancer Symposium to Feature Oncotype DX® DCIS Study in Press Program on Friday, December 12|
|Genomic Health Announces Third Quarter 2014 Financial Results and Reports Continued Growth in U.S. Invasive Breast Cancer Business|
|NanoString Technologies Highlights Important Results from Prosigna Decision Impact Study Presented at the 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium|
|NanoString Technologies Updates Prosigna FDA Labeling to Provide Greater Insight into Probability of Breast Cancer Recurrence Between Year 5 and 10 After Diagnosis|
Click above to view more mutual fund data and stats for dx - Dynex Capital Inc.